MedTrace Logo

COPD Care Pathway Among Patients With Cancer

NCT05984680 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2026-05-05

No results posted yet for this study

Summary

This study gathers information for the development of a COPD care pathway for patients with cancer that reduces the treatment burden of patients, implements critical components of COPD care, and overcomes common barriers to COPD care in the community oncology clinic.

Conditions

Interventions

OTHER

Observational Phase 2, Group I

Noninterventional study

OTHER

Observational Phase 2, Group II

Noninterventional study

OTHER

Observational Phase 3

Noninterventional study

OTHER

Observational Phase 1

Noninterventional study

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Thomas Lycan, MD · Wake Forest Baptist Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-27
Primary Completion
2026-03-25
Completion
2026-03-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05984680 on ClinicalTrials.gov